| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |